Medicine and Therapeutics
Li Ka Shing Institute of Health Sciences
Qualifications 2017 M.P.H. (Public Health Medicine), The University of Manchester, United Kingdom 2015 Ph.D. (Cardiac Electrophysiology), The University of Cambridge, United Kingdom 2014 M.B.B.S. (Clinical Medicine), Imperial College London, United Kingdom 2012 M.A., The University of Cambridge, United Kingdom 2008 B.A. Hons. (Pre-clinical Medicine), The University of Cambridge, United Kingdom Academic Appointments 2016 Assistant Professor (Clinical), Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong 2015 Assistant Professor, School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Professional Memberships and Fellowships - Fellow, European Society of Cardiology (FESC) (2016) - Chartered Scientist, The Science Council (CSci) (2016) - Fellow, Institute of Biomedical Sciences (FIBMS) (2016) - Fellow, Royal Society of Public Health (FRSPH) (2016) - Fellow, Linnean Society of London (FLS) (2014) - Fellow, Cambridge Philosophical Society (FCPS) (2009) - Member, Royal Society of Medicine (2005)
Pre-clinical and clinical cardiac electrophysiology; Inflammation and endothelial dysfunction in cardio-metabolic disorders; Stem cell and cardiovascular regeneration; Epidemiology of cardiovascular diseases.
Fu, H., Li, G., Liu, C., Li, J., Cheng, L., Yang, W., Tse, G., Zhao, J., Liu, T. (2016) Probucol prevents atrial ion channel remodeling in an alloxan-induced diabetes rabbit model. Oncotarget. PMID: 27863381. DOI: 10.18632/oncotarget.13339.